This is an article highlighting the Kyowa Kirin Shine A Light on XLH campaign in EMEA and the virtual exhibition is intended for people in the United Kingdom, Ireland, Finland, Denmark, Norway and Sweden.

We’re thrilled to announce that Monday, 16th May - International Day of Light - marked the launch of the new Kyowa Kirin International Shine A Light on XLH campaign and virtual exhibitionOpen in new window across the UK and Nordics.

Shine A Light Introduction Video

The exhibition has been created with a focus on education, support, and empowerment. A space where people living with X-Linked Hyperphosphataemia (XLH) - a rare, genetic and progressive renal phosphate wasting disorder that causes abnormalities in the bones, muscles and joints - can recognise their experiences in the stories and lives of others, learn about their condition, and access information and support.

Designed with Teamwork/Wa at its core to be an immersive and interactive space at the intersection of art and science, people perhaps not directly impacted by XLH can also go to learn about the condition, and what they can do to help advocate for and support the XLH community. Some people living with XLH face many challenges throughout their care journey and these can include:

  • A lack of awareness amongst the general public - which can lead to people feeling misunderstood and unheard
  • A long journey to an accurate diagnosis, sometimes as a result of lower awareness of XLH amongst the healthcare community, and misdiagnosis
  • Limited access to the right care and support for XLH

The exhibition itself is all about the stories and lives of those 11 individuals who we have partnered with over the last 18 months in the creation of this campaign - and we pass on our heartfelt thanks to each and every one of them: Tia and Anu, Shauneen, Emily, Benjamin and Isabella, Annette, Heidi, and Sonia Sr, Sonia Jr, and Ainhoa.

Initially approved for roll-out in the UK, Ireland, Denmark, Norway, Finland and Sweden as an English-language version of the exhibition, we have high hopes and grand ambitions for the future of Shine A Light and look forward to further collaborating and launching the exhibition in other countries over the coming months.

This is very much only the start.

For more information about Kyowa Kirin International Shine A Light on XLH campaign please follow on LinkedInOpen in new window

More Kyowa Kirin "Patients" Stories

Celebrating another year of diverse initiatives around the world: RDD 2022 in Asia Pacific

Patients | November 21, 2022Open in new window

Celebrating another year of diverse initiatives around the world: RDD 2022 in Japan

Patients | October 20, 2022Open in new window

Providing high-quality pharmaceuticals to patients around the world

Sustainability | September 22, 2022

Striving to create life-changing “Only-one value” that brings smiles to patients

Innovation | July 25, 2022

Kyowa Kirin International: It's Time to Shine A Light on XLH

Patients | June 27, 2022

Kyowa Kirin CEO Miyamoto’s Message on Pride Month

People & Culture | June 9, 2022

Pharmacovigilance Activities (Part II): Adopting a Momotaro Mindset to Overcome Challenges - Global PV Function Member Dialogue -

Patients | March 10, 2022Open in new window

Pharmacovigilance Activities (Part I): Bringing Smiles to Patients by Supporting Medicinal Product Safety Monitoring Activities on a Global Scale

Patients | February 22, 2022Open in new window

Kyowa Kirin International Celebrates the UN’s International Day of Persons with Disabilities in EMEA

People & Culture | January 20, 2022

Kyowa Kirin International: Around the world challenge

People & Culture | December 17, 2021Open in new window

Kyowa Kirin North America: Honoring The Caregiver, Everyday Heroes, During National Family Caregivers Month

Patients | November 19, 2021

Kyowa Kirin's Effort to Realize a Sustainable Society

Sustainability | October 11, 2021

Our Financial Strategy for Creating Life-changing Value

Growth | September 9, 2021

Changes in society caused by COVID-19 and the impact on Kyowa Kirin

Growth | August 19, 2021

Bio Adventure Hands-On Experience Sessions: Become a drug discovery researcher During Your Summer Break

Sustainability | July 27, 2021Open in new window

AMGEN AND KYOWA KIRIN TO JOINTLY DEVELOP AND COMMERCIALIZE KHK4083, A PHASE 3-READY, POTENTIAL FIRST-IN-CLASS TREATMENT FOR ATOPIC DERMATITIS

News Release | June 1, 2021

MEI Pharma and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting

News Release | May 20, 2021

White Paper on the unrecognized burden of XLH in adults in Europe

Patients | July 13, 2020

Return to Stories